Connect with us

Stock News

Psychedelic drug contender stocks drop after FDA rejects MDMA treatment

Published

on


Shares of companies developing treatments based on psilocybin and other psychedelic drugs moved lower on Monday after the U.S. Food and Drug Administration rejected use of MDMA for post-traumatic stress disorder.

Continue Reading

Stock News

Why investors should be worried about the market’s ‘invincibility syndrome’

Published

on


Too much optimism means there aren’t many left to buy stocks, says hedge fund manager.

Continue Reading

Stock News

Amex sees 6% growth in spending, and its stock heads higher

Published

on


The company says new member benefits are resonating with younger generations.

Continue Reading

Stock News

America is doing better than the media or our politicians tell us. Here’s proof.

Published

on


Washington, D.C. doesn’t work. You know what does? America itself.

Continue Reading

Trending